Home
Rabbit Anti-Goat IgG(H+L), Human SP ads-FITC

Rabbit Anti-Goat IgG(H+L), Human SP ads-FITC

Name: Rabbit Anti-Goat IgG(H+L), Human SP ads-FITC
SKU: 6164-02
Price: 93 USD
Availability: InStock

Cat. No.:

6164-02

Rabbit Anti-Goat IgG(H+L)-FITC antibody with minimal reactivity to human serum proteins for use in flow cytometry, immunohistochemistry / immunocytochemistry, and western blot assays.

$93.00

Size	Price (USD)	Quantity
1.0 mg	$93.00

Qty

Technical Bulletin Safety Datasheet

Frozen newborn mouse rib section was stained with Goat Anti-Type II Collagen-UNLB (SB Cat. No. 1320-01) followed by Rabbit Anti-Goat IgG(H+L), Human SP ads-FITC (SB Cat. No. 6164-02) and DAPI.

FLISA plate was coated with purified goat IgG. Immunoglobulin was detected with Rabbit Anti-Goat IgG(H+L), Human SP ads-FITC (SB Cat. No. 6164-02).

Product Specifications

More Information
Isotype	Rabbit IgG
Isotype Control	Rabbit IgG-FITC
Specificity	Reacts with the heavy and light chains of goat IgG
Source	Pooled antisera from rabbits hyperimmunized with goat IgG
Cross Adsorption	Human serum proteins (SP); may react with immunoglobulins from other species and the light chains of other goat immunoglobulins
Purification Method	Affinity chromatography on goat IgG covalently linked to agarose
Conjugate	FITC (Fluorescein)
Buffer Formulation	Phosphate buffered saline containing < 0.1% sodium azide
Clonality	Polyclonal
Concentration	1.0 mg/mL
Volume	1.0 mL
Recommended Storage	2-8°C; Avoid exposure to light
Applications	Quality tested applications for relevant formats include - ELISA ¹ FLISA Other referenced applications for relevant formats include - Flow Cytometry ^2-6 Immunohistochemistry-Frozen Sections ⁷ Immunohistochemistry-Paraffin Sections ^8-10 Immunocytochemistry ¹¹ Western Blot ^12-14
RRID Number	AB_2796236

Documentation

Technical Bulletin Safety Datasheet

Certificate of Analysis Lookup

Enter the Catalog Number and Lot Number for the Certificate of Analysis you wish to view

Need help with this product?

Email technical support

or call 800.722.2255

Other Conjugates and Formulations

Citations

1. Boxx GM, Kozel TR, Nishiya CT, Zhang MX. Influence of mannan and glucan on complement activation and C3 binding by Candida albicans. Infect Immun. 2010;78:1250-9. (ELISA)
2. Fu S, Gong F, Xie C, Zhu W, Wang W, Shen H, et al. S100A12 on circulating endothelial cells surface in children with Kawasaki disease. Pediatr Res. 2010;68:165-8. (FC)
3. Rezaee F, Rellick SL, Piedimonte G, Akers SM, O'Leary HA, Martin K, et al. Neurotrophins regulate bone marrow stromal cell IL-6 expression through the MAPK pathway. PLoS One. 2010;5(3):e9690. (FC)
4. Sekiya I, Ojima M, Suzuki S, Yamaga M, Horie M, Koga H, et al. Human mesenchymal stem cells in synovial fluid increase in the knee with degenerated cartilage and osteoarthritis. J Orthop Res. 2012;30:943-9. (FC)
5. Gong F, Zhang Y, Xie C, Zhu W, Wang W, Fu S, et al. Expression of receptor for advanced glycation end products (RAGE) on the surface of circulating endothelial cells is upregulated in Kawasaki disease. Pediatr Res. 2012;71:720-4. (FC)
6. Hegde M, Corder A, Chow KK, Mukherjee M, Ashoori A, Kew Y, et al. Combinational targeting offsets antigen escape and enhances effector functions of adoptively transferred T cells in glioblastoma. Mol Ther. 2013;21:2087-101. (FC)
7. Kreft KL, Verbraak E, Wierenga-Wolf AF, van Meurs M, Oostra BA, Laman JD, et al. The IL-7Rα pathway is quantitatively and functionally altered in CD8 T cells in multiple sclerosis. J Immunol. 2012;188:1874-83. (IHC-FS)
8. Crijns AP, de Graeff P, Geerts D, ten Hoor KA, Hollema H, van der Sluis T, et al. MEIS and PBX homeobox proteins in ovarian cancer. Eur J Cancer. 2007;43:2495-505. (IHC-PS)
9. Ando K, Brion J, Stygelbout V, Suain V, Authelet M, Dedecker R, et al. Clathrin adaptor CALM/PICALM is associated with neurofibrillary tangles and is cleaved in Alzheimer's brains. Acta Neuropathol. 2013;125:861-78. (IHC-PS)
10. Ahmed L, Nalwoga H, Arnes JB, Wabinga H, Micklem DR, Akslen LA. Increased tumor cell expression of Axl is a marker of aggressive features in breast cancer among African women. APMIS. 2015 May 25. doi: 10.1111/apm.12403. [Epub ahead of print]. (IHC-PS)
11. Hosper NA, van den Berg PP, de Rond S, Popa ER, Wilmer MJ, Masereeuw R, et al. Epithelial-to-mesenchymal transition in fibrosis: collagen type I expression is highly upregulated after EMT, but does not contribute to collagen deposition. Exp Cell Res. 2013;319:3000-9. (ICC)
12. Rayes J, Roumenina LT, Dimitrov JD, Repessé Y, Ing M, Christophe O, et al. The interaction between factor H and VWF increases factor H cofactor activity and regulates VWF prothrombotic status. Blood. 2014;123:121-5. (WB)
13. Wu X, Sagave J, Rutkovskiy A, Haugen F, Baysa A, Nygård S, et al. Expression of bone morphogenetic protein 4 and its receptors in the remodeling heart. Life Sci. 2014;97:145-54. (WB)
14. Matsebatlela TM, Anderson AL, Gallicchio VS, Elford H, Rice CD. 3,4-Dihydroxy-benzohydroxamic acid (Didox) suppresses pro-inflammatory profiles and oxidative stress in TLR4-activated RAW264.7 murine macrophages. Chem Biol Interact. 2015;233:95-105. (WB)